World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
33859
World Ranking
10063
National Ranking
5182

Research.com Recognitions

  • 2019 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2014 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Dan Theodorescu is affiliated with the University of Arizona in the United States. Their research output spans various topics primarily in medicine, with a focus on bladder and urothelial cancer treatments, epigenetics and DNA methylation, urinary and genital oncology studies, cancer immunotherapy and biomarkers, ferroptosis and cancer prognosis, cancer research and treatments, as well as immune cell function and interaction.

Theodorescu has a substantial publication record in the fields of medicine and biochemistry, genetics, and molecular biology. Their subfields of study highlight a concentration in surgery, molecular biology, oncology, pulmonary and respiratory medicine, and immunology.

Frequent publication venues for Theodorescu include:

  • Journal of Clinical Oncology
  • Cancer Research
  • The Journal of Urology
  • Clinical Cancer Research
  • iScience

Among their peer collaborators, Theodorescu has worked repeatedly with James C. Costello, David J. McConkey, Tahlita C.M. Zuiverloon, Teemu D. Laajala, and Florus C. de Jong.

Recent notable publications include:

  • Advances in bladder cancer biology and therapy, 2020, Nature Reviews. Cancer
  • Bladder cancer, 2023, Nature Reviews Disease Primers
  • An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer, 2021, Nature Communications
  • Assessment of Luminal and Basal Phenotypes in Bladder Cancer, 2020, Scientific Reports
  • Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy, 2020, Communications Biology

Throughout their career, Theodorescu has been recognized with several awards, including fellowship in the American Association for the Advancement of Science in 2019, membership in the National Academy of Medicine since 2014, and membership in the Association of American Physicians.

Best Publications

  • Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    Chetan Bettegowda;Chetan Bettegowda;Mark Sausen;Rebecca J. Leary;Isaac Kinde

  • TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

    Patrick J. Killela;Zachary J. Reitman;Yuchen Jiao;Chetan Bettegowda

  • Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder

    Yaoting Gui;Guangwu Guo;Yi Huang;Xueda Hu

  • Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

    David M. Good;Petra Zürbig;Àngel Argilés;Hartwig W. Bauer

  • The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations

    Yuanbin Ru;Katerina J. Kechris;Boris Tabakoff;Paula Hoffman

  • Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation

    Guangwu Guo;Xiaojuan Sun;Chao Chen;Song Wu

  • Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis

    Dan Theodorescu;Stefan Wittke;Mark M Ross;Michael Walden

  • Advances in bladder cancer biology and therapy

    Linda L. Tran;Jin-Fen Xiao;Neeraj Agarwal;Jason E. Duex

  • TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL

    Hai Yan;P.J. Killela;Z.J. Reitman;Y. Jiao

  • Metastasis: a therapeutic target for cancer

    Patricia S Steeg;Dan Theodorescu

  • Clinical proteomics: A need to define the field and to begin to set adequate standards.

    Harald Mischak;Rolf Apweiler;Rosamonde E. Banks;Mark Conaway

  • Recommendations for Biomarker Identification and Qualification in Clinical Proteomics

    Harald Mischak;Guenter Allmaier;Rolf Apweiler;Teresa Attwood

  • A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery

    J. K. Lee;D. M. Havaleshko;H. Cho;John N Weinstein

  • TERT promoter mutations and telomerase reactivation in urothelial cancer

    Sumit Borah;Linghe Xi;Arthur J. Zaug;Arthur J. Zaug;Natasha M. Powell;Natasha M. Powell

  • RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.

    John J. Gildea;M. Jabed Seraj;Gary Oxford;Michael A. Harding

  • Cellular Disposal of miR23b by RAB27-Dependent Exosome Release Is Linked to Acquisition of Metastatic Properties

    Marie Stampe Ostenfeld;Dennis K. Jeppesen;Jens R. Laurberg;Anders T. Boysen

  • Cancer incidence after localized therapy for prostate cancer

    Kihyuck Moon;George J. Stukenborg;Jessica Keim;Dan Theodorescu;Dan Theodorescu

  • Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate.

    Dong-Soon Im;Christopher E. Heise;Michael A. Harding;Susan R. George

  • Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression

    Isabelle Cornil;Dan Theodorescu;Shan Man;Meenhard Herlyn

  • Isolation and Identification of Potential Urinary Microparticle Biomarkers of Bladder Cancer

    David M Smalley;Nicholas E Sheman;Kristina Nelson;Dan Theodorescu

Frequent Co-Authors

Henry F. Frierson
Henry F. Frierson University of Virginia
Mark R. Conaway
Mark R. Conaway University of Virginia
Harald Mischak
Harald Mischak University of Glasgow
Martin A. Schwartz
Martin A. Schwartz Yale University
Michael Dean
Michael Dean National Institutes of Health
David L. Brautigan
David L. Brautigan University of Virginia
Christopher A. Moskaluk
Christopher A. Moskaluk University of Virginia
Bogdan Czerniak
Bogdan Czerniak The University of Texas MD Anderson Cancer Center
Lyuba Varticovski
Lyuba Varticovski National Institutes of Health
Jan Novak
Jan Novak University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if becoming a physician is right for you? There are diverse online pathways that lead to rewarding careers in medicine and healthcare.

Nurses seeking advanced roles may consider the most affordable online DNP programs, which can open doors to leadership and practitioner positions. If you're drawn to pharmaceuticals, explore online Pharm D programs to become a Doctor of Pharmacy and gain expertise in medication management.

For those interested in health data and systems, an HIM degree online offers the skills needed to manage patient information, ensure privacy, and support clinical care processes. Alternatively, roles in administration are growing, and you might find a good fit by checking how much is medical billing and coding school—a practical route to quick entry into the healthcare field.

Each of these options allows you to build expertise and advance your career from anywhere, offering flexibility and affordability as you shape your future in healthcare.

Best Scientists Citing Dan Theodorescu

Trending Scientists

Recently Published Articles